Published in Am Health Drug Benefits on December 01, 2014
The role of DNA methylation in the pathophysiology and treatment of bipolar disorder. Neurosci Biobehav Rev (2016) 0.78
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview. Int J Mol Sci (2016) 0.76
Association of CACNA1C Variants with Bipolar Disorder in the Korean Population. Psychiatry Investig (2016) 0.75
Update on schizophrenia and bipolar disorder: focus on cariprazine. Neuropsychiatr Dis Treat (2016) 0.75
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol Psychiatry (2017) 0.75
Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications. Int J Bipolar Disord (2016) 0.75
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res (2004) 29.02
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry (2002) 6.99
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs (2005) 5.84
The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry (1996) 4.93
Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry (2003) 3.74
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010) 3.72
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry (2003) 3.59
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry (2007) 3.40
Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry (2004) 3.23
Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2005) 3.20
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Treatment of bipolar disorder. Lancet (2013) 2.93
Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord (2006) 2.74
Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2009) 2.48
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry (1996) 2.01
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry (2009) 1.87
Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord (2004) 1.74
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry (2003) 1.72
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
The effect of medication adherence on health care utilization in bipolar disorder. Manag Care Interface (2006) 1.59
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry (2009) 1.59
Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry (2003) 1.48
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs (2003) 1.41
A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders. Bipolar Disord (2004) 1.25
Hepatotoxicity to sodium valproate: a review. Gut (1984) 1.24
Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Compr Psychiatry (2000) 1.16
Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder. Br J Psychiatry (2006) 1.14
Using electronic health record-based tools to screen for bipolar disorder in primary care patients with depression. J Am Board Fam Med (2012) 1.13
An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J Affect Disord (2011) 1.12
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry (2014) 1.10
Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder. Psychiatr Serv (2009) 1.09
Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use. J Psychiatr Pract (2005) 1.06
Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs (2009) 1.05
The Mood Disorder Questionnaire: A Simple, Patient-Rated Screening Instrument for Bipolar Disorder. Prim Care Companion J Clin Psychiatry (2002) 1.03
Psychosocial treatments for bipolar disorders. Psychiatr Clin North Am (2005) 0.99
Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. Am J Health Syst Pharm (2009) 0.98
The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study. Ann Gen Psychiatry (2009) 0.98
Treatment options for bipolar depression: a systematic review of randomized, controlled trials. J Clin Psychopharmacol (2010) 0.97
Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications. Clin Neuropharmacol (2011) 0.97
Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder. J Clin Psychiatry (2006) 0.96
Missed bipolarity and psychiatric comorbidity in women with postpartum depression. Bipolar Disord (2008) 0.95
The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord (2011) 0.95
Clinical correlates of first-episode polarity in bipolar disorder. Compr Psychiatry (2006) 0.94
Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord (2010) 0.94
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry (2007) 0.93
Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population. Value Health (2007) 0.92
Psychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge Survey. Psychiatr Serv (2011) 0.89
Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis. Psychiatr Serv (2011) 0.88
Costs associated with attempted suicide among individuals with bipolar disorder. J Ment Health Policy Econ (2010) 0.88
Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review. Pharmacopsychiatry (2010) 0.88
Screening for bipolar disorder. Am J Manag Care (2007) 0.87
The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. J Affect Disord (2006) 0.87
Comorbidity in bipolar disorder: a framework for rational treatment selection. Hum Psychopharmacol (2004) 0.86
Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population. J Manag Care Pharm (2008) 0.83
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatr Serv (2011) 0.82
Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials. Clin Ther (2009) 0.82
The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation. J Toxicol Clin Toxicol (2001) 0.80
First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand (2013) 0.80
Consequences of delayed diagnosis of bipolar disorders. Encephale (2011) 0.78
Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. Am J Manag Care (2014) 0.78
The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice. Drugs (2009) 0.78
Sustained unemployment in psychiatric outpatients with bipolar disorder: frequency and association with demographic variables and comorbid disorders. Bipolar Disord (2010) 0.78
Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. Acta Psychiatr Scand (2011) 0.78
A model of the economic impact of a bipolar disorder screening program in primary care. J Clin Psychiatry (2009) 0.77
Quetiapine monotherapy for bipolar depression. Neuropsychiatr Dis Treat (2008) 0.77
First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo. J Affect Disord (2013) 0.76